SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
SRTS

Sensus Healthcare, Inc. (NASDAQ:SRTS)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$2.26-$0.10 (-4.24%)
 
Market cap
$37.2M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 26, 2016
Market Cap$37.20M-43.8%
Revenue (ttm)$16.62M-53.3%
Net Income-$16.04M-433.4%
EPS-$0.97-417.9%
Shares Out16.46M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume122,016
Open$2.39
Previous Close$2.36
Day's Range$2.19 - $2.41
52-Week Range$2.14 - $5.49
Beta1.19
AnalystsBuy
Price Target$4.75(+110.18%)
Earnings DateFeb 11, 2027

About SRTS

Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.

Address
851 Broken Sound Parkway NW, Boca Raton, FL, 33487, US
Market Cap
37 million
Employees
60
Industrial Classification
Medical - Devices

Sensus Healthcare, Inc. Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
90th Percentile Overall Score
SRTS InsiderScore:92 / 99

Sensus Healthcare, Inc. scored higher than 90% of companies evaluated by InsiderBuying, and ranked 3rd out of 57 stocks in the healthcare sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Sensus Healthcare, Inc. bought $665.3K of stock across 8 purchases in the last 90 days, the largest of them $183.0K.

Stake Increase

The average purchase added about 12% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$983.84K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From SRTS’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-4.24%
5 Days
-1.74%
1 Month
-21.25%
6 Months
-29.15%
1 Year
-43.78%

$SRTS stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in SRTS holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by SRTS's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

SRTS Estimated quarterly lobbying spending

Source: U.S. Senate LDA

SRTS Revenue by Segment or Geography

SRTS's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New SRTS patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to SRTS from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in SRTS

VTIVanguard Morningstar Total Stock Market ETF$1.07M
VXFVanguard Extended Market ETF$426.89K
DFASDimensional - US Small Cap ETF$246.05K
DFSVU.S. Small Cap Value Portfolio ETF Class Shares$174.10K
DFACDimensional - US Core Equity 2 ETF$104.00K
IWCiShares Micro-Cap ETF$99.33K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from SRTS’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
91.58
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
72

News check: Q3 2026 earnings with margin expansion and 1,000th system milestone sale signal strong commercial and operational progress for SRTS.

Recent Insider Activity

Buys
18
Sells
0
Buy Value
$983.84K
Distinct Buyers
4

Insider Score Trend Over Time

+2.7 since Sep 24
0255075100Sep 24 — Insider Score 88.9Sep 25 — Insider Score 92.4Sep 26 — Insider Score 92.1Sep 27 — Insider Score 92.2Sep 28 — Insider Score 92.2Sep 29 — Insider Score 91.9Sep 30 — Insider Score 91.7Oct 1 — Insider Score 91.5Oct 2 — Insider Score 54.0Oct 3 — Insider Score 91.3Oct 4 — Insider Score 91.2Oct 5 — Insider Score 91.2Oct 6 — Insider Score 91.0Oct 7 — Insider Score 90.6Oct 8 — Insider Score 90.5Oct 9 — Insider Score 90.4Oct 10 — Insider Score 90.2Oct 11 — Insider Score 90.6Oct 12 — Insider Score 90.6Oct 13 — Insider Score 90.3Oct 14 — Insider Score 90.1Oct 15 — Insider Score 90.0Oct 16 — Insider Score 90.0Oct 17 — Insider Score 89.8Oct 18 — Insider Score 90.0Oct 19 — Insider Score 89.7Oct 20 — Insider Score 89.5Oct 21 — Insider Score 89.4Oct 22 — Insider Score 89.3Oct 23 — Insider Score 89.3Oct 24 — Insider Score 89.3Oct 25 — Insider Score 89.1Oct 26 — Insider Score 89.0Oct 27 — Insider Score 89.2Oct 28 — Insider Score 89.1Oct 29 — Insider Score 88.9Oct 30 — Insider Score 88.2Oct 31 — Insider Score 87.9Nov 1 — Insider Score 87.9Nov 2 — Insider Score 88.1Nov 3 — Insider Score 87.7Nov 4 — Insider Score 87.3Nov 5 — Insider Score 86.4Nov 6 — Insider Score 85.7Nov 7 — Insider Score 85.5Nov 8 — Insider Score 86.0Nov 9 — Insider Score 86.0Nov 10 — Insider Score 84.5Nov 11 — Insider Score 84.4Nov 12 — Insider Score 84.0Nov 13 — Insider Score 82.8Nov 14 — Insider Score 81.9Nov 15 — Insider Score 82.2Nov 16 — Insider Score 81.9Nov 17 — Insider Score 80.0Nov 18 — Insider Score 86.5Nov 19 — Insider Score 88.8Nov 20 — Insider Score 92.7Nov 21 — Insider Score 92.0Nov 22 — Insider Score 91.6Sep 24Oct 23Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.